An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant

Clinical trial NCT02285647 · COMPLETED

Trial details

NCT number: NCT02285647
Sponsor: Tesaro, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2014-09-01
Primary completion: 2015-04-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.